Stocks · Korea
183490
KOSDAQ
Enzychem Lifesciences
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+0.00%
1M+0.00%
3M+0.00%
6M+0.00%
1Y-12.78%
YTD-33.91%
52W high1,766원
52W low—
From 52W high-43.94%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 266억 | -147억 | -251억 | -55.0% |
| 2023 | 760억 | -144억 | -94억 | -18.9% |
| 2024 | 774억 | -132억 | -221억 | -17.1% |
| 2025 | 678억 | -143억 | -181억 | -21.2% |
| Quarterly | ||||
| 2024 4Q | 185억 | -47억 | -161억 | -25.3% |
| 2025 1Q | 208억 | -26억 | -18억 | -12.3% |
| 2025 2Q | 164억 | -37억 | -30억 | -22.4% |
| 2025 3Q | 165억 | -37억 | -33억 | -22.6% |
| 2025 4Q | 141억 | -44억 | -99억 | -31.1% |
| 2026 1Q | 149억 | -32억 | -19억 | -21.8% |
Company
Address: 충청북도 제천시 바이오밸리로 59
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-05-26[기재정정]주요사항보고서(자기주식취득신탁계약체결결정) Major
- 2026-05-13분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.